Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-Ranging Study of Indacaterol in COPD
NCT00098228Phase 2Completed
- Sponsor
- Novartis
- Start
- Jul 2004
- Primary completion
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of indacaterol in chronic obstructive pulmonary disease (COPD), sponsored by Novartis. Started Jul 2004; status: completed.
02
Drugs
indacaterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00098228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00098228.